يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Daniil, Stroyakovskiy"', وقت الاستعلام: 1.36s تنقيح النتائج
  1. 1
    IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups With EGFR Mutations or Metastases in the Liver or Brain

    المؤلفون: Naoyuki Nogami, Mark A. Socinski, Delvys Rodriguez-Abreu, Federico Cappuzzo, Makoto Nishio, Daniil Stroyakovskiy, Anthony Lee, Gene Grant Finley, Geetha Shankar, Tony Mok, Christian Thomas, Robert M. Jotte, Ilze Bara, Shelley Coleman, Fabrice Barlesi, David Merritt, Denis Moro-Sibilot, Wei Yu, Francisco Orlandi, Darren Wan-Teck Lim, Martin Reck, Liza C. Villaruz, Joachim G.J.V. Aerts

    المساهمون: Pulmonary Medicine, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Gustave Roussy (IGR), German Center for Lung Research, CHU de Grenoble-Alpes, Moscow City Oncology Hospital, National Stream and Aquatic Ecology Center, Biological and Physical Resources Staff, USDA

    المصدر: Journal of Thoracic Oncology, 17(2), 309-323. International Association for the Study of Lung Cancer
    JOURNAL OF THORACIC ONCOLOGY
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (2), pp.309-323. ⟨10.1016/j.jtho.2021.09.014⟩

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Bevacizumab, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Population, Antibodies, Monoclonal, Humanized, Carboplatin, chemistry.chemical_compound, Atezolizumab, Carcinoma, Non-Small-Cell Lung, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, education, Chemotherapy, education.field_of_study, Intention-to-treat analysis, Brain Neoplasms, business.industry, Liver Neoplasms, Hazard ratio, Brain, ErbB Receptors, Liver, Paclitaxel, chemistry, Mutation, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97d28ac16d7f223dfc27864765b1d672Test
    https://doi.org/10.1016/j.jtho.2021.09.014Test


    أضف إلى المفضلة
  2. 2
    IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

    المؤلفون: Anthony Lee, Francisco Orlandi, Daniil Stroyakovskiy, Gene Grant Finley, Shelley Coleman, Makoto Nishio, Mark A. Socinski, Christian Thomas, Geetha Shankar, Robert M. Jotte, Federico Cappuzzo, Denis Moro-Sibilot, Shengchun Kong, Martin Reck, Delvys Rodriguez-Abreu, Fabrice Barlesi, Mark McCleland, Naoyuki Nogami, Wei Zou

    المصدر: Journal of Thoracic Oncology. 16:1909-1924

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, Chemotherapy, medicine.medical_specialty, Lung Neoplasms, Paclitaxel, Bevacizumab, business.industry, medicine.medical_treatment, First line, Antibodies, Monoclonal, Humanized, Survival Analysis, Confidence interval, Carboplatin, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Overall survival, Humans, Medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71786a00e9bbdd4666e9b6e994827910Test
    https://doi.org/10.1016/j.jtho.2021.07.009Test


    أضف إلى المفضلة
  3. 3
    OA14.02 IMpower131: Final OS Results of Carboplatin + Nab-Paclitaxel ± Atezolizumab in Advanced Squamous NSCLC

    المؤلفون: Alan Sandler, Ross A. Soo, Tien Hoang, Marcus Ballinger, V. Graupner, Henry Jacob Conter, Ihor Vynnychenko, Mark A. Socinski, Maen A. Hussein, Toshiyuki Kozuki, Daniil Stroyakovskiy, Kuan Chieh Huang, Robert M. Jotte, Frederico Cappuzzo, D. Rodriguez Abreu, Mark McCleland, Shawn W. Sun, Helen Jessop

    المصدر: Journal of Thoracic Oncology. 14:S243-S244

    مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, chemistry.chemical_compound, chemistry, business.industry, Atezolizumab, Internal medicine, Medicine, business, Carboplatin, Nab-paclitaxel

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::101a94c7bb707632261457869040d2dbTest
    https://doi.org/10.1016/j.jtho.2019.08.484Test


    أضف إلى المفضلة
  4. 4
    134PD Primary PFS and safety analyses of a randomized phase III study of carboplatin + paclitaxel +/− bevacizumab, with or without atezolizumab in 1L non-squamous metastatic NSCLC (IMpower150)

    المؤلفون: Denis Moro-Sibilot, M.A. Socinski, Fabrice Barlesi, Frederico Cappuzzo, Naoyuki Nogami, Francisco Orlandi, Delvys Rodriguez-Abreu, Martin Reck, Christian Thomas, Daniil Stroyakovskiy

    المصدر: Journal of Thoracic Oncology. 13:S77-S78

    مصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Carboplatin/paclitaxel, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Non squamous, Atezolizumab, 030220 oncology & carcinogenesis, Internal medicine, medicine, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::6c0ebf493a2abe875f4d138524708c0cTest
    https://doi.org/10.1016/s1556-0864Test(18)30409-x


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث